- NXTM signed a one-year extension of its existing agreement with DaVita Inc to supply blood tubing sets to DaVita centers.

Other headlines for [NXTM]

• NXTM 11/3/2008 07:12am
  NxStage Medical, Inc. Achieves milestone with 3,000 End-Stage Renal Disease Patients Receiving Daily Home Hemodialysis Therapy- Co announced that 3,000 end-stage renal disease patients are now prescribed to receive more...
  
• NXTM 11/3/2008 07:05am
  NxStage Medical, Inc. Reports Q3 -$0.33 v -$0.33e, R $30.5M v $31.1Me- Guides Q4 $33-35M v $33.8Me - Guides FY08 $125-128M v $127.4M (previous guidance of $130-$135M). - Q3 GM 16% v 14% y/y
  
• NXTM 10/24/2008 10:32am
  NxStage Medical, Inc. Reports Positive Interim Quality of Life Results from Landmark FREEDOM Study - Study Comparing Clinical and Economic Benefits of its Daily Home Hemodialysis Therapy with Thrice-Weekly In-Center more...
  
• NXTM 10/8/2008 09:18am
  NxStage Medical, Inc. Canaccord Adams Raised NXTM to Buy from Hold
  

Healthcare sector headlines

• CUR Today 08:02am
  Neuralstem Inc Collaborates with Hospital in Taiwan to Develop Additional ALS Stem Cell Clinical Trials- The collaboration will focus on Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) with Dr. more...
  
• SVA Today 08:01am
  Sinovac Biotech Announces share buyback of up to $2M (5.5% of market cap)
  
• PRX Today 08:01am
  Par Pharmaceutical Companies Inc. Announces successful completion of Bioequivalence Studies for Ondansetron Thin Film- The ondansetron thin film product is being developed for the prevention of chemotherapy-induced nausea and more...
  
• CSKI Today 08:01am
  China Sky One Medical, Inc. Names Yu-Bo Hao new CFO- He replaces Yu-kun Zhang, who had served as interim CFO since June, 2008. - Mr. Hao has been employed at China Sky One in various capacities since June, 2008. - From more...
  
• THRX Today 08:01am
  Theravance Inc Announces positive Phase 2b results for LABA, '444 in the Horizon Asthma Development Programme with GSK- The study, which was designed to evaluate the efficacy of five doses of '444 administered more...